|
KLHDC2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.06560005053558E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.384000E-03 |
| Normal-vs-Stage2 |
2.083700E-03 |
| Normal-vs-Stage3 |
6.59872156916208E-12 |
| Normal-vs-Stage4 |
4.81670000551659E-08 |
| Stage1-vs-Stage2 |
1.009400E-01 |
| Stage1-vs-Stage3 |
1.42650000001243E-06 |
| Stage1-vs-Stage4 |
1.036060E-04 |
| Stage2-vs-Stage3 |
1.710180E-01 |
| Stage2-vs-Stage4 |
1.682210E-01 |
| Stage3-vs-Stage4 |
8.203600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.33619998293955E-09 |
| Normal-vs-AfricanAmerican |
1.168060E-02 |
| Normal-vs-Asian |
6.322600E-01 |
| Caucasian-vs-AfricanAmerican |
4.156800E-01 |
| Caucasian-vs-Asian |
4.464200E-01 |
| AfricanAmerican-vs-Asian |
6.696800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.92710316990497E-11 |
| Normal-vs-Female |
3.724500E-03 |
| Male-vs-Female |
6.300300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.681400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.79036999999882E-05 |
| Normal-vs-Age(61-80Yrs) |
4.87020002104543E-09 |
| Normal-vs-Age(81-100Yrs) |
1.999200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.132600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.218200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.831000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.646200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.281800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.883000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.757830E-01 |
| Normal-vs-Grade 2 |
4.239700E-03 |
| Normal-vs-Grade 3 |
3.50169999663308E-08 |
| Normal-vs-Grade 4 |
1.62436730732907E-12 |
| Grade 1-vs-Grade 2 |
8.064200E-03 |
| Grade 1-vs-Grade 3 |
3.154800E-04 |
| Grade 1-vs-Grade 4 |
3.77690001496234E-09 |
| Grade 2-vs-Grade 3 |
1.375880E-02 |
| Grade 2-vs-Grade 4 |
8.72746319657836E-13 |
| Grade 3-vs-Grade 4 |
6.88679999694131E-08 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.588000E-01 |
| Normal-vs-ccB subtype |
1.64956936998806E-12 |
| ccA subtype-vs-ccB subtype |
1.06600284155434E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.60129999996028E-06 |
| Normal-vs-N1 |
1.67377223192489E-12 |
| N0-vs-N1 |
2.95409999995222E-06 |
|
|
